Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Combination Therapy With Corticosteroids and JAK Inhibitors in Bullous Pemphigoid

NCT06561256 is registered in ClinicalTrials.gov with Chao Ji as lead sponsor.

NCT NCT06561256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06561256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Combination Therapy With Corticosteroids and JAK Inhibitors in Bullous Pemphigoid
Lead sponsor
Chao Ji
Phase
Observational
Overall status
Completed
Start date
January 1, 2022
Completion date
July 31, 2024
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bullous pemphigoid, corticosteroids, janus kinase inhibitor